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The effects of modification of the in vitro embryo culture media (IVC) 
with the addition of urokinase-type plasminogen activator (u-PA) on the yield 
and/or quality of bovine embryos were examined in two experiments. In Experi-
ment 1, denuded embryos were cultured in semi-defined synthetic oviductal fluid 
(SOF) for seven days, while in Experiment 2 embryos were co-cultured with cu-
mulus cell monolayer in a serum-containing SOF medium. Plasminogen activator 
activity (PAA) and plasminogen activator inhibition (PAI) were determined in all 
spent IVC media. At the activity used (5 IU/ml), u-PA had no effect either on in 
vitro embryo production rates or on embryo quality as revealed by gene expres-
sion analysis of 10 important mRNA transcripts related to apoptosis, oxidation, 
implantation and metabolism. PAA and PAI analysis indicated the need for well-
balanced plasminogen activators and inhibitors as a culture environment for em-
bryo development. However, more research is needed to unveil the mechanism by 
which u-PA is involved in in vitro embryo production systems.  
Key words: In vitro embryo production, in vitro embryo culture media, 
cleavage, u-PA receptor, bovine 
Plasminogen activators (PAs) have been implicated in several physiologi-
cal reproductive processes, including ovulation (Liu, 2004), fertilisation (Liu, 
2007), embryo development (Whiteside et al., 2001), hatching (Kaaekuahiwi and 
Menino, 1990) and implantation (Strickland et al., 1976). There are at least two 
well-described types of PAs, the tissue-type plasminogen activator (t-PA) and 
the urokinase-type plasminogen activator (u-PA), which convert the abundant 
proenzyme plasminogen to plasmin (Saksela, 1985). Unrestrained activity of the 
plasminogen activators / plasmin system (PAs / PL system) is prevented by spe-
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cific inhibitors, binding to either PAs (plasminogen activator inhibitors, PAIs) or 
plasmin (plasmin inhibitors, PIs) (Saksela, 1985). 
Urokinase-PA is synthesised and released as a single-chain proenzyme 
(pro-u-PA) with little or no activity (Blasi et al., 1987). Activation of pro-u-PA is 
facilitated through binding to a specific cell-membrane receptor (u-PAR), thus 
localising the plasminogen activation near the cell surface (Vassalli et al., 1985). 
PAs and u-PAR mRNA expression, as well as PAs activity, were found to be 
upregulated in a spatiotemporal manner after a GnRH-induced gonadotropin 
surge in the bovine periovulatory follicle, indicating their significant contribution 
to ovulation (Dow et al., 2002). In the same study, u-PAR mRNA was found to 
be primarily localised in the granulosa and theca cells, 6 h after the gonadotropin 
surge, while in vitro maturation of denuded bovine oocytes did not result in any 
increase in u-PA activity, suggesting that increased u-PA might not be of oocyte 
origin, but is physiologically provided by cumulus cells (Park et al., 1999). 
u-PA mRNA was found to be highly expressed in bovine zygotes, it was 
reduced at 2- to 4-cell stage embryos, followed by an upregulation in morula and 
blastocyst stage. Plasminogen activator activity (PAA) was detected in all in vitro 
embryo culture media, with 60% of it being attributed to u-PA activity (White-
side et al., 2001). Messenger RNA expression and/or activity of u-PA have been 
also detected in human blastocysts produced in vitro (Khamsi et al., 1996). Addi-
tion of u-PA in the in vitro culture (IVC) medium of bovine cumulus cell-
enclosed embryos, at concentrations adjusting PAA close to that of the in vivo 
environment, increased embryo development to early morula stage (Papaniko-
laou et al., 2008). u-PA is also present in late stage cultured in vivo produced bo-
vine embryos; it is mostly produced by intact embryos and trophoblastic vesicles 
rather than embryonic discs (Berg and Menino, 1992). 
In the rat, transcriptional activity of u-PA was first detected in the 2-cell 
stage embryos and onward to the blastocyst stage, whereas mRNA expression of 
t-PA was found only in oocytes and 2-cell stage embryos (Zhang et al., 1994). In 
the same study, PAA was detected in the culture media of oocytes and embryos 
and most of it was attributed to u-PA, clearly demonstrating that u-PA activity is 
determinant for early embryo development and implantation. 
We hypothesised that u-PA addition in culture media would favour em-
bryo development. In this context, we investigated the effect of exogenous u-PA 
on denuded embryos, cultured in serum-free semi-defined media, and on em-
bryos co-cultured with cumulus cells in serum-containing media. 
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Materials and methods 
Experimental design  
In the first experiment (Exp. 1), 1631 putative zygotes were used. In the 
second experiment (Exp. 2), 629 putative zygotes were used for IVC modification. 
In vitro embryo production (IVP) 
All chemicals were purchased from Sigma-Aldrich (Taufkirchen, Munich, 
Germany), unless otherwise noted. 
For both experiments bovine ovaries were collected from local abattoirs 
and 2–8 mm follicles were aspirated for the collection of cumulus-oocyte com-
plexes (COCs). 
For gene expression analysis, day 7 blastocysts (pools of 5, four replicates) 
of each group were snap frozen into liquid nitrogen and were stored at –80 °C. 
Experiment 1: Effect of u-PA addition in IVC, on denuded embryos cultured  
under semi-defined conditions  
Bovine embryos were produced as previously described with slight modi-
fications (Wydooghe et al., 2014). For in vitro maturation (IVM), groups of 50–
55 COCs were placed in 500 μl of TCM-199 supplemented with 20 ng/ml epi-
dermal growth factor (EGF) and 50 mg/ml gentamicin. Then, COCs were incu-
bated for 24 h in humidified air with 5% CO2 at 39 °C. Frozen semen was 
thawed and separated through a discontinuous Percoll density gradient [45 and 
90% (v/v), GE Healthcare Biosciences, Uppsala, Sweden], followed by a wash-
ing step. For in vitro fertilisation (IVF), the final sperm concentration of 1 × 106 
spermatozoa/ml was adjusted in 500 μl of IVF-TALP [bicarbonate-buffered Ty-
rode’s solution, supplemented with bovine serum albumin (BSA, 6 mg/ml; 
A8806) and heparin 20 mg/ml] medium already containing the oocytes. Gametes 
were co-incubated for at least 22 h at 39 °C under 5% CO2 in air and maximum 
humidity. All presumptive embryos (n = 1631 in 8 replicates) were vortexed to 
remove cumulus cells, transferred in groups of 25 to 400 μl of synthetic oviduc-
tal fluid (SOF) containing 5 μg/ml insulin, 5 μg/ml transferrin, 5 ng/ml selenium 
and 0.4% BSA. At this stage, IVC medium was modified with the addition of u-
PA from human urine (U0633, EC 3.4.21.73) at a final activity of 5 IU/ml. Em-
bryo cultures were covered with mineral oil and incubated at 39 °C, under an at-
mosphere of 5% CO2, 5% O2 and 90% N2, for seven days. Cleavage rates were 
estimated 45 h post insemination (pi) and blastocyst formation rates on day 7. 
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Experiment 2: Effect of u-PA addition in IVC, on embryos cultured on a cumulus 
cell monolayer under serum-containing conditions 
Bovine embryos were produced as previously described (Dovolou et al., 
2014; Krania et al., 2015). 
COCs were matured as in Exp. 1 in TCM-199, supplemented with 10 ng/ml 
EGF and 10% v/v of fetal calf serum (FCS), and were fertilised with swim-up 
separated sperm (1 × 106 spermatozoa/ml in Tyrode’s medium) as previously de-
scribed in detail (Dovolou et al., 2014). The day of fertilisation was considered 
as day 0 (d0), which was also the day of cumulus cells monolayer preparation. 
Only putative zygotes (n = 629 in 6 replicates), were selected for the IVC. 
Groups of 25 denuded embryos were transferred to the cumulus cells monolayer 
IVC media (400 μl) and covered with mineral oil. The culture medium consisted 
of SOF enriched with 5% FCS and 6 mg/ml BSA, modified or not with u-PA, at 
a final activity of 5 IU/ml, and embryos were cultured under the same conditions 
as in Exp 1. 
Preparation of cumulus cells monolayer (CC monolayer) 
The cumulus cells (CC) monolayer was prepared using 55 in vitro matured 
COCs, as previously described (Goovaerts et al., 2009). Cumulus cells were me-
chanically removed by multiple pipetting, using a stripping pipette (Cook Medi-
cal, Bloomington, IN, USA). The CC suspension was centrifuged for 10 min at 
67 × g and the pellet was resuspended in SOF containing 5% FCS at a concentra-
tion of 25 × 103 viable CC/ml. Then, 500 μl of the SOF-CC suspension was 
transferred to a 4-well culture dish (Nunc®-Thermofisher Scientific, Roskilde, 
Denmark). Cells were incubated at 39 °C under 5% CO2, in air and maximum 
humidity, for 24 h (until day 1). A CC monolayer was formed onto the bottom of 
the dish; SOF medium was discarded and replaced by 400 μl of fresh pre-
equilibrated SOF. 
RNA extraction and reverse transcription (RT) 
A Pico Pure RNA isolation kit® (Arcturus, Mountain View, CA, USA) 
was used for total RNA extraction. DNase treatment (Invitrogen, Gaithesburg, 
MD, USA) was performed in all RNA purification columns to ensure that no ge-
nomic DNA (gDNA) contamination would interfere with the results. 
First strand cDNA was immediately synthesised from the total amount of 
RNA using the High-Capacity cDNA reverse transcription kit® (Applied Biosys-
tems, Foster City, CA, USA). Each RT reaction consisted of 15 μl of DNase-
treated RNA and an equal volume of RT master mix (RT random primers, 
dNTPs Mix, RT buffer, RNase inhibitor and MultiScribe reverse transcriptase). 
Thermal cycling conditions for RT were 25 °C for 10 min, 37 °C for 2 h fol-
lowed by a denaturation step at 85 °C for 5 min and flash cooling at 4 °C. 
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Real-Time Polymerase Chain Reaction (RT-PCR) 
Genes related to apoptosis (survivin, BBC3 and BCL2L1), fructose transport 
and metabolism (GLUT-5), implantation (PLAC8), oxidative stress (MnSOD), 
carbohydrate metabolism (AKR1B1), regulation of cell proliferation (COX-2) and 
proteolysis (PLG and PLAUR) were studied. 
Primers used for RT-PCR to amplify the candidate genes were designed 
with PRIMER 3 software and purchased from Vbc biotech (Vienna, Austria). 
The primer sequences are listed in Table 1. 
Table 1 
Primers used for RT-PCR 
Genes GenBank Accession no. Primer sequence 5’Æ3’ Amplicon size (bp) 
GAPDH NM_001034034 (F) 5’-CAAGTTCAACGGCACAGTCAAGG-3’ (R) 5’-ACATACTCAGCACCAGCATCACC-3’ 123 
SDHA NM_174178.2 (F) 5’–GCAGAACCTGATGCTTTGTG-3’ (R) 5’-CGTAGGAGAGCGTGTGCTT-3’ 185 
YWHAZ NM_174814.2 (F) 5’-GCATCCCACAGACTATTTCC-3’ (R) 5’-GCAAAGACAATGACAGACCA-3’ 120 
PLAC8  NM_001076987 (F) 5’-AATGAATGCTGTCTGTGCGGAAC-3’ (R) 5’-AGTGCGATTGGCTCTCCTTCTG-3’ 167 
AKR1B1 NM_001012519 (F) 5’-AGGAGAAAGTGGTGAAGCGTGAG-3’ (R) 5’-ATGAGGTAGAGGTCCAGGTAGTCC-3’ 138 
survivin NM_001001855 (F) 5’-GCCGTCAACCGCTGGATTTG-3’ (R) 5’-CGTTCTCAGTGGGACAGTGGATG-3’ 198 
BBC3 XM_002695182.2 (F) 5’-CATGAAGAGCAAATGAGCCAAACG-3’ (R) 5’-GCAGAGCACAGGATTCACAGTC-3’ 193 
COX-2 NM_174445 (F) 5’-TCTGGTGCCTGGTCTGATGATG-3’ (R) 5’-GGATTAGCCTGCTTGTCTGGAAC-3’ 127 
BCL2L1 NM_001077486 (F) 5’-TGACTGTGGCTGGTGTGGTTC-3’ (R) 5’-CAATGGTGGCTGGACGGAGAG-3’ 123 
GLUT-5 NM_001101042 (F) 5’-ATAGCTGCCTTTGGGTCGTC-3’ (R) 5’-CAGCAAGGTTCCTTTTCTGCC-3’ 243 
MnSOD NM_201527 (F) 5’-GCACCACAGCAAGCACCAC-3’ (R) 5’-GGGCTCAGATTTGTCCAGAAGATG-3’ 156 
PLG NM_173951 (F) 5’-GGCGGTGGTGTTCCTACTTCTC-3’ (R) 5’-GTCTGTCTCCTCCTCACACTTGG-3’ 163 
PLAUR NM_174423.3 (F) 5’-GTCCTGAGTGTGTGGGAAGG-3’ (R) 5’-CAGTAGCATCTCGACCAGGG-3’ 177 
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RT-PCR was performed in LightCycler® 2.0 Carousel-Based System 
(Roche-Applied Science, Manheim, Germany) using the Kapa SYBR® Fast qPCR 
kit (Kapa Biosystems, Woburn, MA, USA). All RT-PCR reactions mixtures pre-
pared in a final volume of 20 μl containing 1 μl embryo’s cDNA of the same con-
centration, 200 nM of each specific primer, 1x KAPA SYBR FAST qPCR Master 
Mix-Universal and 250 ng/μl BSA (New England Biolabs B900S, Ipswich, MA, 
USA) for prevention of DNA polymerase and template binding to the glass capil-
laries used for this PCR system. RT-PCR cycling conditions for amplification were 
1 cycle for 10 min at 95 °C, followed by 55 cycles of 10 sec at 95 °C, of 10 sec at 
58 °C and of 15 sec at 72 °C; each amplicons’ specificity was verified by a melting 
curve analysis given by the LightCycler software. Three endogenous reference 
genes (GAPDH, YWHAZ and SDHA) were selected for data normalisation, using 
the geNorm™ programme (Vandesompele et al., 2002). Fold changes in the rela-
tive gene expression of each target gene were determined using the formula 2–ΔΔCt. 
Plasminogen Activator Activity and Plasminogen Activator Inhibition  
(PAA and PAI) 
In both experiments, day 7 IVC spent media of all groups were centri-
fuged (120 × g, 20 min, at room temperature) and the supernatant was stored at  
–20 °C, for PAA and PAI analysis. 
PAA was determined by a spectrophotometric method, using the chro-
mogenic substrate S-2251 (Chromogenix, Milan, Italy), as previously described 
(Smokovitis et al., 1987). 
PAI activity was determined by a previously described procedure (Rekkas 
et al., 2002). 
Statistical analysis 
Cleavage and blastocyst formation rates were analysed using the chi-
square test. Independent samples test was used for the analysis of possible differ-
ences on both gene expression and PAA or PAI results. Moreover, linear regres-
sion analysis was also performed to trace possible relations between PAA, PAI 
and embryo developmental results. 
Data were analysed using the statistical software package SPSS® 17.0 for 
Windows. In all cases, the probability of P < 0.05 was considered significant. 
 
Results 
Experiment 1 
Supplementation of semi-defined IVC medium with 5 IU/ml u-PA had no 
effect on cleavage rate, on day 7 blastocyst formation rates (Table 2) and on gene 
expression (Fig. 1). In the u-PA groups, the total PAA was significantly higher 
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than in the controls (P < 0.0001). Based on the PAI results against u-PA (u-PAI), 
no significant difference was found between the two groups studied. In contrast, 
the corresponding PAI levels against t-PA (t-PAI) were significantly higher in 
the u-PA treated group. Both PAA and PAI results are shown in Table 3. 
Table 2 
Effects of u-PA addition in IVC on embryo development (mean ± SEM) 
 Group 
Putative  
zygotes 
(N) 
Cleavage 
(%) 
Day 7 blastocysts/
putative zygotes
(%) 
Day 7 blastocysts/ 
cleaved zygotes 
(%) 
Experiment 1 Control 775 80.1 ± 3.4 23.5 ± 1.8 29.2 ± 1.6 
 u-PA 856 78.7 ± 2.8 25.1 ± 2.7 32.0 ± 2.9 
Experiment 2 Control 310 74.2 ± 2.7 25.1 ± 2.9 33.9 ± 3.7 
 u-PA 319 76.2 ± 4.0 22.8 ± 3.1 30.0 ± 3.9 
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Fig. 1. Effect of u-PA addition in IVC on the quality of day 7 blastocysts (Experiment 1).  
Gene expression results are depicted in two different scale graphs and are presented as mean ± SD 
of the four replicates 
Table 3 
Plasminogen Activator Activity (PAA) and Plasminogen Activator Inhibition (PAI) in day 7 (D7) 
IVC spent medium (mean ± SEM) 
 Group PAA (u-PA IU/0.1 ml) 
PAI 
(t-PA IU/0.1 ml) 
PAI 
(u-PA IU/0.1 ml) 
Experiment 1 Control 1.5 ± 0.1a 22.3 ± 1.7a 0.24 ± 0.02  
 u-PA (D7) 7.1 ± 0.5b 30.1 ± 1.5b 0.28 ± 0.04  
 u-PA (D0) 8.2 ± 0.3b 32.2 ± 0.9b 0.36 ± 0.04  
Experiment 2 Control 0.9 ± 0.1 16.6 ± 0.7  0.17 ± 0.02  
 u-PA (D7) 0.8 ± 0.1a 15.2 ± 0.7  0.15 ± 0.01  
 u-PA (D0) 1.4 ± 0.1b 17.4 ± 0.9  0.16 ± 0.01  
a, bDifferent superscripts in the same column denote significant differences between groups in each 
experiment (P < 0.0001). Day 0 (D0) u-PA-treated culture media used as an internal control to test 
the effectiveness of modification of the IVC medium 
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Experiment 2 
No differences were found in cleavage rate, in day 7 blastocyst formation 
rates (Table 2) and in gene expression (Fig. 2) between the control and the u-PA 
treated group. PAA and PAI levels did not differ between the two groups studied 
(P > 0.05). On day 0 PAA was higher in experiment 1 than in experiment 2. The 
results referring to PAA and PAI are presented in Table 3.  
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Fig. 2. Effect of u-PA addition on relative mRNA abundance (mean ± SD) of the ten genes studied. 
Embryos cultured with a cumulus cell monolayer in SOF medium with FCS (Experiment 2) 
 
 
Discussion 
The results of the present study indicate that our initial hypothesis has not 
been confirmed, since neither the yield nor the quality of blastocysts was af-
fected by the addition of u-PA. 
In a previous study it was reported that the addition of u-PA to the IVC 
medium significantly increased the 4-cell stage bovine embryo rates, when cul-
tured for 48 h enclosed by their cumulus cells (Papanikolaou et al., 2008). Cumu-
lus cells in an oviduct epithelial cell-conditioned culture medium have been con-
sidered beneficial during early cleavage stages of in vitro-derived bovine zygotes 
(Thomas and Seidel, 1993), albeit those cells are metabolically active and there-
fore, it is necessary to unravel all possible, but complex, cell-to-embryos interac-
tions. Nowadays, the use of somatic cells in bovine IVP has been abandoned; 
here, cumulus cells were solely added to facilitate the study of possible effects of 
u-PA on embryo development. It has been proposed that u-PA activity is physio-
logically provided by cumulus cells instead of oocytes (Park et al., 1999). It is 
therefore possible that cumulus cells might moderate u-PA activity. In this study, 
co-culture of embryos surrounded by their cumulus cells led to poor IVP results 
(approximately 10–12% day 7 blastocyst rates, data not shown) when cultured until 
the blastocyst stage (both in control and u-PA treated groups). Hence, we used the 
cumulus cell monolayer as an alternative protocol to provide embryos with those 
cells that are possibly carrying the u-PAR, thereby producing plasmin activity. 
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In Exp. 1, a significant increase in PAs activity and PAI against t-PA (t-
PAI) in the u-PA-treated group compared to the control was observed. PAA lev-
els were in positive correlation with t-PAI levels (P < 0.0001). In contrast, no 
changes were recorded in the inhibitory activity against u-PA (u-PAI) between 
the two groups studied. Even though we are not able to discriminate between u-
PA or t-PA activity contribution to the total PAA, through the experiments car-
ried out in this study, PAA results are in accordance with the inclusion of exoge-
nous u-PA in semi-defined media in the absence of any cell. In bovine blasto-
cysts, 60% of the total PAA produced in the spent media was attributed to u-PA 
activity (Whiteside et al., 2001). Another interesting finding is that u-PA treat-
ment caused an increase in the t-PAI levels but not in the u-PAI, indicating that 
excessive u-PA or plasmin activity might be physiologically restrained by a spe-
cific type of PAI release. Among the described PAIs, PAI-2 is regarded as a rela-
tively poor inhibitor of t-PA and is associated with the two-chain u-PA more 
than 400 times higher than with the two-chain t-PA (Thorsen et al., 1988). Con-
sequently, in our case, this significant increase in PAI levels against t-PA is 
probably indicative of a subsequent increase of the PAI-1. Supplements con-
tained in our semi-defined medium used for embryo culture, such as selenium 
and insulin, have been reported to alter u-PA and PAI-1 expression, respectively 
(Alessi et al., 1988; Yoon et al., 2001). 
In Exp. 2, no significant differences were recorded either in PAA or PAI 
results between untreated and u-PA treated spent media. However, in u-PA-
treated spent media, PAA was positively related to t-PA inhibitory activity (t-
PAI; linear regression, P < 0.05). Secreted inhibitors are essential to neutralise 
excessive PAA produced in the medium, and cumulus cells might play a role in 
this process to support embryonic development. Secretion rate of PAs and/or 
PAIs can be altered by several hormones or hormone-like substances such as go-
nadotropins, sex steroids, prostaglandins E1 or E2, several growth factors and 
substances raising the cAMP (Saksela, 1985; Blasi et al., 1987); all these sub-
stances might have been provided to the embryo culture by FCS addition, which 
might explain the differences in PAA between the two treatment groups at the 
starting point (day 0). We hypothesised that the presence of cumulus cells and 
FCS in the culture media might alter the PAA in the spent media by releasing 
PAs and/or PAIs, thus affecting the PAA observed in the spent media. These re-
sults may explain why PAA and PAI levels in the spent media of u-PA-treated 
embryos did not show any divergence from the control groups. 
Control and u-PA-treated embryos were analysed for relative mRNA ex-
pression of transcripts involved in various biological processes. The set of se-
lected genes included genes related to apoptosis [survivin (Park et al., 2007), 
BCL2L1 (Cory et al., 2003) and BBC3 (Hikisz and Kiliańska, 2012)], to antioxi-
dant protection and embryo quality [MnSOD (Lonergan et al., 2003)], to implan-
tation [COX-2, PLAC8 and AKR1B1 (El-Sayed et al., 2006)], and metabolism 
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(GLUT-5). As no difference was detected in either experiment, we infer that ei-
ther u-PA does not affect the aforementioned functions, or its action is exerted 
through different pathways that have not been analysed in this study. Lastly, 
PLG and PLAUR mRNA expression were selected to investigate whether u-PA 
addition altered the relative mRNA abundance of those related genes which are 
members of the PAs/PL system. PLG mRNA expression was not detected either 
in control or in u-PA treated embryos, which is in accordance with our previous 
results for PLG expression in control day 7 embryos (Krania et al., 2015). 
Despite its significant role in early and late embryo development, the in-
clusion of exogenous u-PA in the in vitro bovine embryo culture medium, at a 
final activity of 5 IU/ml, did not have any effect on embryo yield and/or quality 
under the experimental culture conditions used in this study. Gene expression 
analysis of the produced u-PA-treated blastocysts confirmed the phenotypic in-
variance that arose from IVP results. Investigation of the altered culture envi-
ronment related to PAs and PAIs activity revealed the importance of a culture 
system to maintain a balanced activity between activators and inhibitors in a 
highly regulated manner. 
 
Acknowledgements 
Fotini Krania was financially supported with a PhD scholarship (‘Heraclitus II’) 
through the Operational Programme ‘Education and Lifelong Learning’ (NSRF 2007-
2012) funded by the EU and the Greek government. For all experiments performed at 
Ghent University, Fotini Krania was supported by a short-term mission provided by the 
COST Action FA0702–GEMINI – ‘Maternal interactions with gametes & embryos’. 
 
 
References 
Alessi, M. C., Juhan-Vague, I., Kooistra, T., Declerck, P. J. and Collen, D. (1988): Insulin stimu-
lates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell 
line Hep G2. Thromb. Haemost. 60, 491–494. 
Berg, D. A. and Menino, A. R. Jr. (1992): Bovine embryos produce a urokinase-type plasminogen 
activator. Mol. Reprod. Dev. 31, 14–19. 
Blasi, F., Vassalli, J. D. and Danø, K. (1987): Urokinase-type plasminogen activator: proenzyme, 
receptor, and inhibitors. J. Cell Biol. 104, 801–804. 
Cory, S., Huang, D. C. and Adams, J. M. (2003): The Bcl-2 family: roles in cell survival and onco-
genesis. Oncogene 22, 8590–8607. 
Dovolou, E., Messinis, I. E., Periquesta, E., Dafopoulos, K., Gutierrez-Adan, A. and Amiridis, G. 
S. (2014): Ghrelin accelerates in vitro maturation of bovine oocytes. Reprod. Domest. 
Anim. 49, 665–672. 
Dow, M. P., Bakke, L. J., Cassar, C. A., Peters, M. W., Pursley, J. R. and Smith, G. W. (2002): 
Gonadotropin surge-induced up-regulation of the plasminogen activators (tissue plasmino-
gen activator and urokinase plasminogen activator) and the urokinase plasminogen activa-
tor receptor within bovine periovulatory follicular and luteal  tissue. Biol. Reprod. 66, 
1413–1421. 
 U-PA AND IN VITRO EMBRYO CULTURE 253 
Acta Veterinaria Hungarica 63, 2015 
El-Sayed, A., Hoelker, M., Rings, F., Salilew, D., Jennen, D., Tholen, E., Sirard, M. A., Schel-
lander, K. and Tesfaye, D. (2006): Large-scale transcriptional analysis of bovine embryo 
biopsies in relation to pregnancy success after transfer to recipients. Physiol. Genomics 28, 
84–96. 
Goovaerts, I. G., Leroy, J. L., Van Soom, A., De Clercq, J. B., Andries, S. and Bols, P. E. (2009): 
Effect of cumulus cell coculture and oxygen tension on the in vitro developmental compe-
tence of bovine zygotes cultured singly. Theriogenology 71, 729–738. 
Hikisz, P. and Kiliańska, Z. M. (2012): PUMA, a critical mediator of cell death-one decade on 
from its discovery. Cell Mol. Biol. Lett. 17, 646–669. 
Kaaekuahiwi, M. A. and Menino, A. R. Jr. (1990): Relationship between plasminogen activator 
production and bovine embryo development in vitro. J. Anim. Sci. 68, 2009–2014. 
Khamsi, F., Armstrong, D. T. and Zhang, X. (1996): Expression of urokinase-type plasminogen ac-
tivator in human preimplantation embryos. Mol. Hum. Reprod. 2, 273–276. 
Krania, F., Dovolou, E., Rekkas, C. A., Theodosiadou, E. K., Pappas, I. and Amiridis, G. S. (2015): 
Effects of addition of tissue-type Plasminogen Activator in in vitro fertilization medium on 
bovine embryo development and quality. Reprod. Domest. Anim. 50, 112–120. 
Liu, Y. X. (2004): Plasminogen activator/plasminogen activator inhibitors in ovarian physiology. 
Front. Biosci. 9, 3356–3373. 
Liu, Y. X. (2007): Involvement of plasminogen activator and plasminogen activator inhibitor type 
1 in spermatogenesis, sperm capacitation, and fertilization. Semin. Thromb. Hemost. 33, 
29–40. 
Lonergan, P., Rizos, D., Gutierrez-Adán, A., Moreira, P. M., Pintado, B., de la Fuente, J. and 
Boland, M. P. (2003): Temporal divergence in the pattern of messenger RNA expression in 
bovine embryos cultured from the zygote to blastocyst stage in vitro or in vivo. Biol. Re-
prod. 69, 1424–1431. 
Papanikolaou, T., Amiridis, G. S., Dimitriadis, I., Vainas, E. and Rekkas, C. A. (2008): Effect of 
plasmin, plasminogen activators and a plasmin inhibitor on bovine in vitro embryo produc-
tion. Reprod. Fertil. Dev. 20, 320–327. 
Park, K. W., Choi, S. H., Song, X. X., Funahashi, H. and Niwa, K. (1999): Production of plasmi-
nogen activators (PAs) in bovine cumulus-oocyte complexes during maturation in vitro: ef-
fects of epidermal growth factor on production of PAs in oocytes and cumulus cells. Biol. 
Reprod. 61, 298–304. 
Park, S. Y., Kim, E. Y., Jeon, K., Cui, X. S., Lee, W. D., Kim, N. H., Park, S. P. and Lim, J. H. 
(2007): Survivin acts as anti-apoptotic factor during the development of bovine pre-
implantation embryos. Mol. Reprod. Dev. 74, 582–590. 
Rekkas, C. A., Besenfelder, U., Havlicek, V., Vainas, E. and Brem, G. (2002): Plasminogen activa-
tor activity in cortical granules of bovine oocytes during in vitro maturation. Theriogenology 
57, 1897–1905. 
Saksela, O. (1985): Plasminogen activation and regulation of pericellular proteolysis. Biochim. 
Biophys. Acta 823, 35–65. 
Smokovitis, A., Kokolis, N., Alexopoulos, C., Alexaki, E. and Eleftheriou, E. (1987): Plasminogen 
activator activity, plasminogen activator inhibition and plasmin inhibition in spermatozoa 
and seminal plasma of man and various animal species. Effect of plasmin on sperm motil-
ity. Fibrinolysis 1, 253–257. 
Strickland, S., Reich, E. and Sherman, M. I. (1976): Plasminogen activator in early embryogenesis: 
enzyme production by trophoblast and parietal endoderm. Cell 9, 231–240. 
Thomas, W. K. and Seidel, G. E. Jr. (1993): Effects of cumulus cells on culture of bovine embryos 
derived from oocytes matured and fertilized in vitro. J. Anim. Sci. 71, 2506–2510. 
Thorsen, S., Philips, M., Selmer, J., Lecander, I. and Astedt, B. (1988): Kinetics of inhibition of 
tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor 
type 1 and type 2. Eur. J. Biochem. 175, 33–39. 
254 KRANIA et al. 
Acta Veterinaria Hungarica 63, 2015 
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A. and Speleman, 
F. (2002): Accurate normalization of real-time quantitative RT-PCR data by geometric av-
eraging of multiple internal control genes. Genome Biol. 3 (7), RESEARCH0034. Epub 18 
June 2002. 
Vassalli, J. D., Baccino, D. and Belin, D. (1985): A cellular binding site for the Mr 55,000 form of 
the human plasminogen activator, urokinase. J. Cell Biol. 100, 86–92. 
Whiteside, E. J., Kan, M., Jackson, M. M., Thompson, J. G., McNaughton, C., Herington, A. C. 
and Harvey, M. B. (2001): Urokinase-type plasminogen activator (uPA) and matrix metal-
loproteinase-9 (MMP-9) expression and activity during early embryo development in the 
cow. Anat. Embryol. 204, 477–483. 
Wydooghe, E., Heras, S., Dewulf, J., Piepers, S., Van den Abbeel, E., De Sutter, P., Vandaele, L. 
and Van Soom, A. (2014): Replacing serum in culture medium with albumin and insulin, 
transferrin and selenium is the key to successful bovine embryo development in individual 
culture. Reprod. Fertil. Dev. 26, 717–724.  
Yoon, S. O., Kim, M. M. and Chung, A. S. (2001): Inhibitory effect of selenite on invasion of 
HT1080 tumor cells. J. Biol. Chem. 276, 20085–20092. 
Zhang, X., Kidder, G. M., Zhang, C., Khamsi, F. and Armstrong, D. T. (1994): Expression of 
plasminogen activator genes and enzymatic activities in rat preimplantation embryos. J. 
Reprod. Fertil. 101, 235–240. 
 
 
 
 
